Trends in annual number of ESRD incident cases, unadjusted and adjusted incidence rates of ESRD, and annual percentage change in the U.S. population, 1980-2015

Figure 1.1
Trends in the (a) unadjusted and standardized incidence rates of ESRD, and (b) the annual percentage change in the standardized incidence rate of ESRD in the U.S. population, 1980-2015
(a) Incidence rate per million/year
Incidence rate per million/year
Data Source: Reference Table A.2(2) and special analyses, USRDS ESRD Database. Standardized for age, sex and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.
(b) One-year percentage change in standardized incidence rate
One-year percentage change in standardized incidence rate
Data Source: Reference Table A.2(2) and special analyses, USRDS ESRD Database. Standardized for age, sex and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.

Figure 1.2
Trends in the annual number of ESRD incident cases, by modality, in the U.S. population, 1980-2015
Trends in the annual number of ESRD incident cases, by modality, in the U.S. population, 1980-2015
Data Source: Reference Table D1. Abbreviation: ESRD, end-stage renal disease.

Unadjusted and adjusted incidence rates of ESRD and annual number of ESRD incident cases, overall and by modality and ESRD Network, in the U.S. population, 2015

Figure 1.3
Map of the adjusted incidence rate of ESRD, by Health Service Area, in the U.S. population, 2011-2015
Map of the adjusted incidence rate of ESRD, by Health Service Area, in the U.S. population, 2011-2015
Data Source: Special analyses, USRDS ESRD Database. Standardized for age, sex, and race. The standard population was the U.S. population in 2011. Values for cells with 10 or fewer patients are suppressed. Abbreviation: ESRD, end-stage renal disease.

Figure 1.4
Trends in adjusted ESRD incidence rate, by age group, in the U.S. population, 2000-2015
Trends in adjusted ESRD incidence rate, by age group, in the U.S. population, 2000-2015
Data Source: Reference Table A.2(2) and special analyses, USRDS ESRD Database. Standardized for sex and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.

Figure 1.5
Trends in adjusted ESRD incidence rate, by race, in the U.S. population, 2000-2015
Trends in adjusted ESRD incidence rate, by race, in the U.S. population, 2000-2015
Data Source: Reference Table A.2(2) and special analyses, USRDS ESRD Database. Standardized for age and sex. The standard population was the U.S. population in 2011. Abbreviations; AI/AN: Americans Indian/Alaska Native; NA/PI: Native Hawaiian/Pacific Islander; ESRD, end-stage renal disease.

Figure 1.6
Trends in adjusted ESRD incidence rate, by Hispanic ethnicity, in the U.S. population, 2000-2015
Trends in adjusted ESRD incidence rate, by Hispanic ethnicity, in the U.S. population, 2000-2015
Data Source: Reference Tables A.2(2). Standardized for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.

Trends in annual number of ESRD prevalent cases, unadjusted and adjusted of ESRD, and annual percentage change, in the U.S. population, 1980-2015

Figure 1.7
Trends in the (a) unadjusted and standardized prevalence of ESRD, and (b) annual percentage change in the standardized prevalence of ESRD, in the U.S. population, 1980-2015
(a) Prevalence per million
Prevalence per million
Data Source: Reference Table B.2(2) and special analyses, USRDS ESRD Database. Standardized for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.
(b) One-year percentage change in standardized prevalence
One-year percentage change in standardized prevalence
Data Source: Reference Table B.2(2) and special analyses, USRDS ESRD Database. Standardized for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.

Figure 1.8
Trends in the number of ESRD prevalent cases, by modality, in the U.S. population, 1980-2015
Trends in the number of ESRD prevalent cases, by modality, in the U.S. population, 1980-2015
Data Source: Reference Table D.1. Abbreviation: ESRD, end-stage renal disease.

Unadjusted and adjusted* prevalence of ESRD and annual number of ESRD prevalent cases, by modality and ESRD Network, in the U.S. population, 2015

Figure 1.9
Map of the adjusted  prevalence of ESRD, by Health Service Area, in the U.S. population, 2011-2015*
Map of the adjusted  prevalence of ESRD, by Health Service Area, in the U.S. population, 2011-2015*
Data Source: Special analyses, USRDS ESRD Database. Standardized for age, sex, and race. The standard population was the U.S. population in 2011. *Three Health Service Areas were suppressed because the ratio of unadjusted rate to adjusted rate or adjusted rate to unadjusted rate was greater than 3. Values for cells with 10 or fewer patients are suppressed. Abbreviation: ESRD, end-stage renal disease.

Figure 1.10
Trends in the adjusted prevalence of ESRD, by age group, in the U.S. population, 2000-2015
Trends in the adjusted prevalence of ESRD, by age group, in the U.S. population, 2000-2015
Data Source: Reference Table B.2(2) and special analyses, USRDS ESRD Database. Point prevalence on December 31 of each year. Standardized for sex and race. The standard population was the U.S. population in 2011. Abbreviations: ESRD, end-stage renal disease.

Figure 1.11
Trends in adjusted prevalence of ESRD, by race, in the U.S. population, 2000-2015
Trends in adjusted prevalence of ESRD, by race, in the U.S. population, 2000-2015
Data Source: Reference Table B.2(2) and special analyses, USRDS ESRD Database. Point prevalence on December 31 of each year. Standardized for age and sex. The standard population was the U.S. population in 2011. Abbreviations NH/PI: Native Hawaiian/Pacific Islander; AI/AN: Americans Indian/Alaska Natives; ESRD, end-stage renal disease.

Figure 1.12
Trends in the adjusted prevalence of ESRD, by Hispanic ethnicity, in the U.S. population, 2000-2015
Trends in the adjusted prevalence of ESRD, by Hispanic ethnicity, in the U.S. population, 2000-2015
Data Source: Reference Tables B.1, B.2(2). Point prevalence on December 31 of each year. Standardized for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.

Figure 1.13
Trends in the number of incident ESRD cases using home dialysis, by type of therapy, in the U.S. population, 1996-2015
Trends in the number of incident ESRD cases using home dialysis, by type of therapy, in the U.S. population, 1996-2015
Data Source: Reference Table D.1. Abbreviations: ESRD, end-stage renal disease.

Number and percentage of incident cases of hemodialysis, peritoneal dialysis, and transplantation by age, sex, race, ethnicity, and primary cause of ESRD, in the U.S. population, 2015

Figure 1.14
Map of the percentage of incident dialysis cases using home dialysis (peritoneal dialysis or home hemodialysis), by Health Service Area, 2011-2015
Map of the percentage of incident dialysis cases using home dialysis (peritoneal dialysis or home hemodialysis), by Health Service Area, 2011-2015
Data Source: Special analyses, USRDS ESRD Database. Values for cells with 10 or fewer patients are suppressed.

Figure 1.15
Trends in number of prevalent ESRD cases using home dialysis, by type of therapy, in the United States, 1996-2015
Trends in number of prevalent ESRD cases using home dialysis, by type of therapy, in the United States, 1996-2015
Data Source: Reference Table D.1. December 31 prevalent ESRD patients. Peritoneal dialysis consists of CAPD and CCPD only. Abbreviations: CAPD, continuous ambulatory peritoneal dialysis; CCPD, continuous cycler peritoneal dialysis; ESRD, end-stage renal disease.

Percentage of prevalent cases of in-center hemodialysis, home hemodialysis, peritoneal dialysis, and transplant by age, sex, race, ethnicity, and primary ESRD diagnosis, in the United States, 2015

Figure 1.16
Map of the percentage of prevalent dialysis cases using home dialysis, by Health Service Area, 2011-2015
Map of the percentage of prevalent dialysis cases using home dialysis, by Health Service Area, 2011-2015
Data Source: Special analyses, USRDS ESRD Database. Values for cells with 10 or fewer patients are suppressed.

Demographic characteristics (% within row)
Clinical characteristics (% within row)

Figure 1.17
Percentage of incident cases who had received >12 months of pre-ESRD nephrology care, by Health Service Area, 2011-2015
Percentage of incident cases who had received >12 months of pre-ESRD nephrology care, by Health Service Area, 2011-2015
Data Source: Special analyses, USRDS ESRD Database. Population only includes incident cases with CMS form 2728. Values for cells with 10 or fewer patients are suppressed. Abbreviations: ESRD, end-stage renal disease; Neph., nephrology.

Figure 1.18
Trends in the distribution (%) of eGFR (ml/min/1.73 m2) among incident ESRD patients, 1996-2015
Trends in the distribution (%) of eGFR (ml/min/1.73 m2) among incident ESRD patients, 1996-2015
Data Source: Special analyses, USRDS ESRD Database. Population only includes incident cases with CMS form 2728. eGFR calculated using the CKD-EPI equation (CKD-EPI eGFR (ml/min/1.73 m2) for those aged ≥18 and the Schwartz equation for those aged <18. Abbreviations: CKD-EPI; chronic kidney disease epidemiology calculation; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease.

Distributions of laboratory values (mean) and treatment characteristics (%), by age, sex, race, ethnicity, and primary cause of ESRD, among incident ESRD cases, 2015

Figure 1.19
Map of mean eGFR at initiation of renal replacement therapy, by Health Service Area, 2011-2015
Map of mean eGFR at initiation of renal replacement therapy, by Health Service Area, 2011-2015
Data Source: Special analyses, USRDS ESRD Database. Population only includes incident cases with CMS form 2728. eGFR calculated using the CKD-EPI equation (CKD-EPI eGFR (ml/min/1.73 m2) for those aged ≥18 and the Schwartz equation for those aged <18. Values for cells with 10 or fewer patients are suppressed. Abbreviations: eGFR, estimated glomerular filtration rate; CKD-EPI, chronic kidney disease epidemiology calculation.

Figure 1.20
Map of average hemoglobin level at initiation of renal replacement therapy, by Health Service Area, 2011-2015
Map of average hemoglobin level at initiation of renal replacement therapy, by Health Service Area, 2011-2015
Data Source: Special analyses, USRDS ESRD Database. Population only includes incident cases with CMS form 2728. Values for cells with 10 or fewer patients are suppressed. Abbreviation: ESRD, end-stage renal disease.

Distribution of duration of pre-ESRD nephrology care, hemoglobin level, and eGFR, by ESRD Network, among incident ESRD cases, 2015